Today please find the second in a three-part series that looks at the changing policy and communications environments and the challenges and opportunities for pharmaceutical marketing. In Part 1 yesterday, what was covered was the fact that there is a growing possibility of a double pincer type movement – one arm that will likely curtail DTC advertising to consumers and a second that will likely dilute the kinds of relationships that industry has with practicing medicine. Either of these alone might have a big impact on pharma marketing, together that is ensured.
Part 2 examines the changing communications landscape – the dynamic growth of digital as we witness a decline in traditional media and a migration by both readers and writers to the digital realm.
This is also available on the EyeonFDA YouTube channel.
Share this:
